In this episode, Dr. Amy Valent and guest Dr. Sarah Osmundson discuss the updated guidelines from the American Academy of Neurology on Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication. These guidelines, developed in collaboration with the American Epilepsy Society and SMFM, provide evidence-based recommendations on anti-seizure medications, perinatal outcomes, and neurodevelopmental impacts for people with epilepsy of childbearing potential. The episode emphasizes the importance of preconception planning and appropriate medication management, addressing the complexities of epilepsy in pregnancy, including congenital malformations and neurodevelopmental outcomes. Tune in to gain valuable insights into the latest recommendations for managing epilepsy in pregnancy. Additional Resources: Practice Guidelines from the AAN, AES, and SMFM Full transcript can be found here. 

Ver todos los episodios